{"name":"Ralexar Therapeutics, Inc.","slug":"ralexar-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ALX-101 Gel 5%","genericName":"ALX-101 Gel 5%","slug":"alx-101-gel-5","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"ALX-101 Gel 5%","genericName":"ALX-101 Gel 5%","slug":"alx-101-gel-5","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE1wVVdHR0k5SUpxbEtnS1o4NUVsQzloMVR3dk40Vl9janllRlpRTEdwRVMxQUpDMXljN25fQV9KMUc0UDZwV29yR1JDU25hYTdhWTRfeEhXd21JaWZMZXVOQlFlWkVaRkc5N3c?oc=5","date":"2022-11-14","type":"pipeline","source":"Wiley Online Library","summary":"Journal of the European Academy of Dermatology and Venereology - Wiley Online Library","headline":"Journal of the European Academy of Dermatology and Venereology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNVlBKa3pyLURjWG93NGtncDhNYngxTTFwNWd4U3Roa1pDRU9heGN6VGU4SzRVTllFZGZybGhLVUNaZmhuU0EtVFE2cmdXSEszak1YVU0yR2ZfYzV2dDdtM1lRUkxKSXhEM3JUZXEwZ1hfeUNQb2ZWSUw5S1Z6Tm1xbUw2UDlNUQ?oc=5","date":"2022-06-06","type":"pipeline","source":"Dermatology Times","summary":"Rosacea Recap: The Science and the Symptom - Dermatology Times","headline":"Rosacea Recap: The Science and the Symptom","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPSkVyLXJveUlyMmRPWXlTVlh4blBHaW1GenU2OXBrQ0lualhaLUR1YlBfN1dMMGVJNHg1dlBMWjhKOXg1WmsyZGFTNk50R1pvakRlWVdISHkyekpqLXdlc0NjNjB6eUxMTmFtb1Y0RHFJSHVIeDFvS3c0OU9QSmh4TlNwSUZiQQ?oc=5","date":"2022-06-06","type":"pipeline","source":"Dermatology Times","summary":"Rosacea Recap: Comparing Treatment Options - Dermatology Times","headline":"Rosacea Recap: Comparing Treatment Options","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}